Beyond Break-Falls: MCMAP and the Will to Fight
Journal of Advanced Military Studies · 19.05.2026 · 17 (1) · 206-230
DOI: 10.21140/mcuj.20261701009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Advanced Military Studies, online erschienen am 15.04.2026. Verfasst von David A. Daigle und 2 weiteren Autor:innen.
Themen: Sturzprophylaxe
Abstract (Originalsprache)
Based on the Marine Corps’ expeditionary advanced base operations (EABO) concept, small units operating in isolation make individual character operationally imperative. This poses a challenge that weapons cannot solve: sustaining a Marine’s will to fight in austere and dispersed conditions. The Marine Corps Martial Arts Program (MCMAP) provides the solution. Established in 2000, MCMAP was designed to forge an indomitable will to fight that transcends weapons and technology. As the program marks its 25th anniversary, it has drifted from that founding purpose—character development has been overshadowed by physical techniques and belt progression. To preserve the modern Marine’s will to fight, the Corps must restore MCMAP to its original mission: forging the ethical warrior ethos that defines professional arms. This article examines MCMAP’s original design through military history, spiritual fitness research, and Marine Corps doctrine, arguing that MCMAP was built to forge character, not chase belts.
Zitieren
APA
Daigle, D. A., Goff, D. V., & Ott, P. N. (2026). Beyond Break-Falls: MCMAP and the Will to Fight. Journal of Advanced Military Studies, 17(1), 206-230. https://doi.org/10.21140/mcuj.20261701009
Vancouver
Daigle DA, Goff DV, Ott PN. Beyond Break-Falls: MCMAP and the Will to Fight. Journal of Advanced Military Studies. 2026;17(1):206-230. doi:10.21140/mcuj.20261701009
BibTeX
@article{Daigle2026,
author = {Daigle, David A. and Goff, Daniel V. and Ott, Peter N.},
title = {Beyond Break-Falls: MCMAP and the Will to Fight},
journal = {Journal of Advanced Military Studies},
year = {2026},
volume = {17},
number = {1},
pages = {206--230},
doi = {10.21140/mcuj.20261701009}
}
EUVIMED